Abeona Therapeutics Inc. ( ABEO) - Key Metrics
ABEO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.10 | -$0.39 | -$0.34 | -$0.36 |
| 2025Q3 | ? | -$0.10 | -$0.39 | -$0.44 |
| 2025Q2 | $0.01 | $2.07 | -$0.36 | -$0.41 |
| 2025Q1 | ? | -$0.24 | -$0.37 | -$0.40 |
ABEO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.41 |
| 2025Q3 | ? | -13.87 |
| 2025Q2 | ? | 0.69 |
| 2025Q1 | ? | -4.92 |
ABEO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -8.18% | ? |
| 2025Q4 | -6.85% | ? |
| 2025Q3 | -8.28% | ? |
| 2025Q2 | -7.27% | ? |
| 2025Q1 | -8.36% | ? |
ABEO
Price: $6.05
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.95 USD
P/E Ratio: 5.54
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 254600
Ebitda: -5.2 millionMarket Capitalization: 364.8 million